Parsons C L
Division of Urology, University of California-San Diego.
Urol Clin North Am. 1994 Feb;21(1):93-100.
Polysaccharide therapy for bladder disease is a novel therapy based on the model of bladder mucus activity and the belief that mucus and exogenous glycosaminoglycans (GAG) have protective properties. Interstitial cystitis is the first disease explored for the potential use of polysaccharide therapy, which appears to be effective in some patients with this syndrome.
用于膀胱疾病的多糖疗法是一种基于膀胱黏液活性模型以及黏液和外源性糖胺聚糖（GAG）具有保护特性这一理念的新型疗法。间质性膀胱炎是首个探索多糖疗法潜在用途的疾病，该疗法在部分患有此综合征的患者中似乎有效。
